Diagnostic and predictive capabilities of the method for the quantification of C-reactive protein in patients with community-acquired pneumonia


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

According to numerous researches the authors emphasize the importance of the quantification of C-reactive protein in patients with community-acquired pneumonia. We gave an analysis of different publications on the given issue. We came to conclusion that available laboratory kits for the quantification of C-reactive protein in blood serum, including instant diagnosis, allow considering the given method as a method of common use for military-medical facilities.

全文:

受限制的访问

参考

  1. Авдеев С.Н., Баймаканова Г.Е., Зубаирова П.А. Возможности С-реактивного белка в диагностике бактериальной инфекции и пневмонии у больных с обострением хронической обструктивной болезни легких // Уральский мед. журн. — 2008. — № 13. — С. 19-24.
  2. Agapakis D.I., Tsantilas D., Pramis P. et al. Coagulation and inflammation biomarkers may help predict the severity of community-acquired pneumonia // Respir. — 2010. — Vol. 15(5). — P. 796—803.
  3. Almirall J., Bolipar I., Vidal J. et al. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia // Chest. — 2004. — Vol. 125. — P. 1335— 1342.
  4. Bafadhel M., Clark T.W., Reid C. et al. Procalcitonin and Creactive protein in hospitalized adult patients with communityacquired pneumonia or exacerbation of asthma or COPD // Chest. — 2011. — 139 (6). — P. 1410—1418.
  5. Bauer S., Lamy O. Role of C-reactive protein in the diagnosis, prognosis and follow-up of community-acquired pneumonia // Rev. Med. Suisse. — 2010. — Vol. 6(269). — P. 2068—2070, 2072— 2073.
  6. Bruns A.H., Oosterheert J.J., Hak E., Hoepelman A.I. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia // Eur. Respir. J. — 2008. — Vol. 32. — P. 726—732.
  7. Castro-Guardiola A., Armengou-Arxe A., Viedjo-Rodriguez A. et al. Differential diagnosis between community-acquired pneumonia and non-pneumonia diseases of the chest in the emergency ward // Eur. J. Intern. Med. — 2000. — Vol. 11. — P. 334—339.
  8. Chalmers J., Singanayagam A., Hill A. C-reactive protein is an independent predictor of severity in community-acquired pneumonia // Am. J. Med. — 2008. — Vol. 121. — P. 219—225.
  9. Coelho L., Povoa P., Almeida E. et al. Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course // Crit. Care. — 2007. — Vol. 11(4). — P. 92.
  10. Espana P.P., Capelastegui A., Bilbao A. et al. Population Study of Pneumonia (PSoP) Group. Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia // Eur. J. Clin. Microbiol. Infect. Dis. — 2012. — Vol. 31(12). — P. 3397—3405.
  11. Flanders S.A., Stein J., Shochat G. et al. Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough // Amer. J. Med. — 2004. — Vol. 116. — P. 529—535.
  12. Garcia Vazquez E., Martines J.A., Menza J. et al. C-reactive protein levels in community-acquired pneumonia // Eur. Respir. J. — 2003. — Vol. 21. — P. 702—705.
  13. Hirschfield G.M., Pepys M.B. C-reactive protein and cardiovascular disease: new insights from an old molecule // Q. J. Med. — 2003. — Vol. 96(11). — P. 793—807.
  14. Hohenthal U., Hurme S., Helenius H. et al. Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia // Clin. Microbiol. Infect. — 2009. — Vol. 15(11). — P. 1026—1032.
  15. Korppi M., Heiskanen-Kosma T., Leininen M. White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children // Eur. Respir. J. — 1997. — Vol. 10. — P. 1125—1129.
  16. Krüger S., Ewig S., Papassotiriou J. et al. CAPNETZ Study Group. Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ // Respir. Res. — 2009. — Vol. 10 (1). — P. 65.
  17. Lehtomaki K. Clinical diagnosis of pneumococcal, adenoviral, mycoplasmal and mixed pneumonias in young men // Eur. Respir. J. — 1988. — Vol. 1. — P. 324—329.
  18. Lobo S.M., Lobo F.R., Bota D.P. et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients // Chest. — 2003. — Vol. 123. — P. 2043—2049.
  19. Macfarlane J., Holmes W., Gard P. et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community // Thorax. — 2001. — Vol. 56. — P. 109—114.
  20. MacLeod C.M., Avery O.T. The occurrence during acute infections of a protein not normally present in the blood : II. Isolation and properties of the reactive protein // J. Exp. Med. — 1941. — Vol. 73(2). — P. 183—190.
  21. McCarthy P.L., Frank A.L., Ablou R.C. et al. Value of the C-reactive protein test in the differentiation of bacterial and viral pneumonia // J. Pediatr. — 1978. — Vol. 92. — P. 454—456.
  22. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update // J. Clin. Invest. — 2003. — Vol. 111. — P. 1805—1812.
  23. Ruiz-Gonzcilez A., Falguera M., Porcel J.M. et al. C-reactive protein for discriminating treatment failure from slow responding pneumonia // Eur. J. Int. Med. — 2010. — Vol. 21. — P. 548—552.
  24. Shine B., de Beer F.C., Pepis M.B. et al. Solid phase radioimmunoassays for human C-reactive protein // Clin. Chim. Acta. — 1981. — Vol. 117. — P. 13—23.
  25. Smith R.P. C-reactive protein in simple community-acquired pneumonia // Chest. — 1995. — Vol. 107. — P. 1028—1031.
  26. Tillet W., Francis T. Serological reaction in pneumonia with a non-protein somatic fraction of Pneumococcus // J. Exp. Med. — 1930. — Vol. 52. — P. 561—571.
  27. Van der Meer V., Neven A., Van den Broek P., Assendelft W. Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review // BMJ. — 2005. — Vol. 331 (7507). — P. 26.
  28. Young Ae Kang, Sung-Youn Kwon, Ho IL Yoon et al. Role of C-Reactive Protein and Procalcitonin in Differentiation of Tuberculosis from Bacterial Community Acquired Pneumonia // Korean J. Intern. Med. — 2009. — Vol. 24(4). — P. 337—342.
  29. Young B., Greeson M., Gripps A.W. et al. C-reactive protein: a critical review // Pathology. — 1991. — Vol. 23. — P. 118—124.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Zaytsev A.A., Kondratyeva T.V., Madzhanova E.R., 2013


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 01975 от 30.12.1992.
##common.cookie##